Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 11

1.

A controlled, evidence-based trial of paliperidone palmitate, a long-acting injectable antipsychotic, in schizophrenia.

Nasrallah HA, Gopal S, Gassmann-Mayer C, Quiroz JA, Lim P, Eerdekens M, Yuen E, Hough D.

Neuropsychopharmacology. 2010 Sep;35(10):2072-82. doi: 10.1038/npp.2010.79. Epub 2010 Jun 16.

2.

Aripiprazole Lauroxil Compared with Paliperidone Palmitate in Patients with Schizophrenia: An Indirect Treatment Comparison.

Cameron C, Zummo J, Desai DN, Drake C, Hutton B, Kotb A, Weiden PJ.

Value Health. 2017 Jul - Aug;20(7):876-885. doi: 10.1016/j.jval.2017.03.010. Epub 2017 May 9. Review.

PMID:
28712616
3.

Critical appraisal of 3-monthly paliperidone depot injections in the treatment of schizophrenia.

Carpiniello B, Pinna F.

Drug Des Devel Ther. 2016 May 24;10:1731-42. doi: 10.2147/DDDT.S86301. eCollection 2016. Review.

4.

Paliperidone palmitate: effectiveness, safety, and the use for treatment of schizophrenia.

Jarema M, Bieńkowski P, Heitzman J, Parnowski T, Rybakowski J.

Psychiatr Pol. 2017 Feb 26;51(1):7-21. doi: 10.12740/PP/64581. Epub 2017 Feb 26. Review. English, Polish.

5.

Profile of paliperidone palmitate once-monthly long-acting injectable in the management of schizophrenia: long-term safety, efficacy, and patient acceptability - a review.

González-Rodríguez A, Catalán R, Penadés R, Garcia-Rizo C, Bioque M, Parellada E, Bernardo M.

Patient Prefer Adherence. 2015 May 25;9:695-706. doi: 10.2147/PPA.S63948. eCollection 2015. Review.

6.

Paliperidone Palmitate Long-Acting Injectable Given Intramuscularly in the Deltoid Versus the Gluteal Muscle: Are They Therapeutically Equivalent?

Yin J, Collier AC, Barr AM, Honer WG, Procyshyn RM.

J Clin Psychopharmacol. 2015 Aug;35(4):447-9. doi: 10.1097/JCP.0000000000000361. Review.

PMID:
26061612
7.

Three-month paliperidone palmitate - a new treatment option for schizophrenia.

Bernardo M, Bioque M.

Expert Rev Clin Pharmacol. 2016 Jul;9(7):899-904. doi: 10.1080/17512433.2016.1191945. Epub 2016 Jun 6. Review.

PMID:
27206330
8.

A critical appraisal of paliperidone long-acting injection in the treatment of schizoaffective disorder.

Chue P, Chue J.

Ther Clin Risk Manag. 2016 Jan 27;12:109-16. doi: 10.2147/TCRM.S81581. eCollection 2016. Review.

9.

Critical evaluation of paliperidone in the treatment of schizophrenia in Chinese patients: a systematic literature review.

Zhang L, Li J, Zhao Y, Su Y, Si T.

Neuropsychiatr Dis Treat. 2016 Jan 11;12:113-31. doi: 10.2147/NDT.S64672. eCollection 2016. Review.

10.

Dosing and Switching Strategies for Paliperidone Palmitate 3-Month Formulation in Patients with Schizophrenia Based on Population Pharmacokinetic Modeling and Simulation, and Clinical Trial Data.

Magnusson MO, Samtani MN, Plan EL, Jonsson EN, Rossenu S, Vermeulen A, Russu A.

CNS Drugs. 2017 Apr;31(4):273-288. doi: 10.1007/s40263-017-0416-1. Review.

PMID:
28258365
11.

Two cases of long-acting paliperidone in adolescence.

Fàbrega M, Sugranyes G, Baeza I.

Ther Adv Psychopharmacol. 2015 Oct;5(5):304-6. doi: 10.1177/2045125315600141. Review.

Supplemental Content

Support Center